IP Library Granted Patent US 12,551,613
Granted Patent B2
US 12,551,613 · App. 17/085,682 · Granted Feb 17, 2026

Implantable drug delivery port

Inventors: Lloyd V. Hansen (Hugo, MN); Cynthia Nelson Konen (Zimmerman, MN); Luis E. Fesser (St. Paul, MN); John P. Mehawej (Plymouth, MN); Todd Hanson (Blaine, MN)
Assignee: Medtronic, Inc.
A61M5/14276A61M5/165A61M2205/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,551,613
App. No.
17/085,682
Granted
Feb 17, 2026
Kind
B2
Abstract

A drug delivery port including a port housing having an inner sidewall defining a fill port cavity and a fill port washer in direct contact with a perimeter edge of the inner sidewall of the port housing such that an intersection between the washer and the perimeter edge define a plurality of filter channels having a cross-sectional flow area of about 0.001 mm 2 to about 0.5 mm 2 that lie within the fluid pathway of the delivery port. The delivery port also includes a port cover coupled and a pierceable septum compressed between the fill port washer and the port cover configured to allow a needle to pierce through the septum to deliver an injectable fluid to the fill port cavity.

Claims (14)

1 . A method of forming an implantable drug delivery port comprising a port housing, a fill port washer, a pierceable septum, and a port cover, the method comprising:

machining the port housing to include an inner sidewall and needle stop defining a fill port cavity for receiving an injectable fluid, wherein the inner sidewall comprises a perimeter edge;

machining at least one of the perimeter edge of the inner sidewall or a first side of the port washer to form a plurality of filter channels, wherein each filter channel defines a cross-sectional flow area when the first side of the port washer is seated in direct contact with the perimeter edge of the inner sidewall; and

coupling the port cover to the port housing so that the pierceable septum is compressed between at least a second side of the fill port washer and the port cover, wherein the port cover defines an aperture positioned over the pierceable septum and is configured so that a needle can pierce through the septum to deliver the injectable fluid to the fill port cavity.

2 . The method of claim 1 , further comprising:

machining the port housing to include an integrated catheter fitting; and

machining the port housing to form a fluid pathway that connects the plurality of filter channels to the catheter fitting.

3 . The method of claim 2 , wherein machining the port housing to form a fluid pathway comprises:

forming a collecting channel coaxially aligned with the fill port cavity and fluidically connected to each of the plurality of filter channels;

machining a first lumen along a central axis of the catheter fitting; and

electrical discharge machining a second lumen to fluidically connect the collecting channel to the first lumen.

4 . The method of claim 1 , wherein coupling the port cover to the port housing comprises:

press fitting the port cover to the port housing, wherein at least one of the port cover or the port housing comprises at least one friction-fit retainer that temporarily secures the port housing to the port cover; and

welding the port housing to the port cover.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2021
From: HANSEN, LLOYD V.; NELSON KONEN, CYNTHIA; FESSER, LUIS E.; MEHAWEJ, JOHN P.; HANSON, TODD A.
To: MEDTRONIC, INC.
Reel/Frame 057499/0971 →
Continuity (1)
Related Publication 20220133992A1 · May 5, 2022
References Cited (63)
US 5045064A · Idriss · 1991 [cited by applicant]
US 5085644A · Watson et al. · 1992 [cited by applicant]
US 5185003A · Brethauer · 1993 [cited by applicant]
US 5281210A · Burke et al. · 1994 [cited by applicant]
US 5527307A · Srisathapat et al. · 1996 [cited by applicant]
US 5575770A · Melsky · 1996 [cited by examiner]
US 5695490A · Flaherty · 1997 [cited by examiner]
US 5702372A · Nelson · 1997 [cited by applicant]
US 5833654A · Powers et al. · 1998 [cited by applicant]
US 5957890A · Mann et al. · 1999 [cited by applicant]
US 6013051A · Nelson · 2000 [cited by applicant]
US 6042579A · Elsberry et al. · 2000 [cited by applicant]
US 6572583B1 · Olsen et al. · 2003 [cited by applicant]
US 6852106B2 · Watson et al. · 2005 [cited by applicant]
US 6962577B2 · Tallarida et al. · 2005 [cited by applicant]
US 7351239B2 · Gill · 2008 [cited by applicant]
US 7366562B2 · Dukesherer et al. · 2008 [cited by applicant]
US 7637897B2 · Ginggen · 2009 [cited by applicant]
US 7803143B2 · Tallarida et al. · 2010 [cited by applicant]
US 7963956B2 · Kunst · 2011 [cited by applicant]
US 8320991B2 · Jascob et al. · 2012 [cited by applicant]
US 8419710B2 · Keimel et al. · 2013 [cited by applicant]
US 8483802B2 · Kalpin et al. · 2013 [cited by applicant]
US 8545484B2 · Haase et al. · 2013 [cited by applicant]
US 8591456B2 · Steinbach · 2013 [cited by applicant]
US 8613724B2 · Lanier, Jr. et al. · 2013 [cited by applicant]
US 8721605B2 · Brandt et al. · 2014 [cited by applicant]
US 8915893B2 · Steinbach · 2014 [cited by applicant]
US 8932271B2 · Hamatake et al. · 2015 [cited by applicant]
US 9079004B2 · Wiley et al. · 2015 [cited by applicant]
US 9427553B2 · Nelson · 2016 [cited by applicant]
US 9433764B2 · East et al. · 2016 [cited by applicant]
US 9744338B2 · East et al. · 2017 [cited by applicant]
US 9782536B2 · Skutnik et al. · 2017 [cited by applicant]
US 9919102B2 · John · 2018 [cited by applicant]
US 9981117B2 · Brandt et al. · 2018 [cited by applicant]
US 9993600B2 · Lanier, Jr. et al. · 2018 [cited by applicant]
US 10238851B2 · Butziger et al. · 2019 [cited by applicant]
US 10376635B2 · Haase · 2019 [cited by applicant]
US 10589024B2 · John · 2020 [cited by applicant]
US 10596362B2 · Fielder et al. · 2020 [cited by applicant]
US 10625060B2 · Børgesen · 2020 [cited by applicant]
US 20050124980A1 · Sanders · 2005 [cited by applicant]
US 20050137537A1 · Watson et al. · 2005 [cited by applicant]
US 20070106280A1 · Utard · 2007 [cited by examiner]
US 20070112291A1 · Børgesen · 2007 [cited by applicant]
US 20100030196A1 · Hildebrand et al. · 2010 [cited by applicant]
US 20160089521A1 · Dragoon et al. · 2016 [cited by applicant]
US 20170325685A1 · Shachar et al. · 2017 [cited by applicant]
US 20180117243A1 · Maguire · 2018 [cited by applicant]
US 20190009014A1 · Chen et al. · 2019 [cited by applicant]
US 20190184139A1 · Nelson et al. · 2019 [cited by applicant]
US 20190269850A1 · Shih et al. · 2019 [cited by applicant]
US 20200061362A1 · Singh et al. · 2020 [cited by applicant]
CN 208838708U · 2019 [cited by applicant]
WO WO0066204A1 · 2000 [cited by applicant]
WO WO2009129474A1 · 2009 [cited by applicant]
WO WO2012138854A1 · 2012 [cited by applicant]
WO WO2013134486A4 · 2013 [cited by applicant]
WO WO2016059162A1 · 2016 [cited by applicant]
WO WO2020046791A1 · 2020 [cited by applicant]
EP Search Report corresponding to EP 21205164.3 dated Apr. 7, 2022. [cited by applicant]
Alcyone Lifesciences, Inc., Bringing Hope to Spinal Muscular Atrophy (SMA) Patients with the Alcyone Lifesciences ThecaFlex DRx™ System Breakthrough Device, Dec. 2, 2019, 3 pages, available at: https://www.prnewswire.co… [cited by applicant]